http://www.tkuhn.ch/bel2nanopub/RA_y6C5KwX3OeeBFoo2Jl_jXSsFWcWERQe2U-yTjlDIpw#Head http://www.tkuhn.ch/bel2nanopub/RA_y6C5KwX3OeeBFoo2Jl_jXSsFWcWERQe2U-yTjlDIpw http://www.nanopub.org/nschema#hasAssertion http://www.tkuhn.ch/bel2nanopub/RA_y6C5KwX3OeeBFoo2Jl_jXSsFWcWERQe2U-yTjlDIpw#assertion http://www.tkuhn.ch/bel2nanopub/RA_y6C5KwX3OeeBFoo2Jl_jXSsFWcWERQe2U-yTjlDIpw http://www.nanopub.org/nschema#hasProvenance http://www.tkuhn.ch/bel2nanopub/RA_y6C5KwX3OeeBFoo2Jl_jXSsFWcWERQe2U-yTjlDIpw#provenance http://www.tkuhn.ch/bel2nanopub/RA_y6C5KwX3OeeBFoo2Jl_jXSsFWcWERQe2U-yTjlDIpw http://www.nanopub.org/nschema#hasPublicationInfo http://www.tkuhn.ch/bel2nanopub/RA_y6C5KwX3OeeBFoo2Jl_jXSsFWcWERQe2U-yTjlDIpw#pubinfo http://www.tkuhn.ch/bel2nanopub/RA_y6C5KwX3OeeBFoo2Jl_jXSsFWcWERQe2U-yTjlDIpw http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://www.tkuhn.ch/bel2nanopub/RA_y6C5KwX3OeeBFoo2Jl_jXSsFWcWERQe2U-yTjlDIpw#assertion http://www.tkuhn.ch/bel2nanopub/RA_y6C5KwX3OeeBFoo2Jl_jXSsFWcWERQe2U-yTjlDIpw#_1 http://purl.obolibrary.org/obo/RO_0002204 http://www.informatics.jax.org/marker/MGI:1339758 http://www.tkuhn.ch/bel2nanopub/RA_y6C5KwX3OeeBFoo2Jl_jXSsFWcWERQe2U-yTjlDIpw#_1 http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI_36080 http://www.tkuhn.ch/bel2nanopub/RA_y6C5KwX3OeeBFoo2Jl_jXSsFWcWERQe2U-yTjlDIpw#_2 http://purl.obolibrary.org/obo/RO_0002204 http://www.informatics.jax.org/marker/MGI:96542 http://www.tkuhn.ch/bel2nanopub/RA_y6C5KwX3OeeBFoo2Jl_jXSsFWcWERQe2U-yTjlDIpw#_2 http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI_36080 http://www.tkuhn.ch/bel2nanopub/RA_y6C5KwX3OeeBFoo2Jl_jXSsFWcWERQe2U-yTjlDIpw#_3 http://purl.obolibrary.org/obo/BFO_0000066 http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?id=10090 http://www.tkuhn.ch/bel2nanopub/RA_y6C5KwX3OeeBFoo2Jl_jXSsFWcWERQe2U-yTjlDIpw#_3 http://www.w3.org/1999/02/22-rdf-syntax-ns#object http://www.tkuhn.ch/bel2nanopub/RA_y6C5KwX3OeeBFoo2Jl_jXSsFWcWERQe2U-yTjlDIpw#_2 http://www.tkuhn.ch/bel2nanopub/RA_y6C5KwX3OeeBFoo2Jl_jXSsFWcWERQe2U-yTjlDIpw#_3 http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate http://www.selventa.com/vocabulary/increases http://www.tkuhn.ch/bel2nanopub/RA_y6C5KwX3OeeBFoo2Jl_jXSsFWcWERQe2U-yTjlDIpw#_3 http://www.w3.org/1999/02/22-rdf-syntax-ns#subject http://www.tkuhn.ch/bel2nanopub/RA_y6C5KwX3OeeBFoo2Jl_jXSsFWcWERQe2U-yTjlDIpw#_1 http://www.tkuhn.ch/bel2nanopub/RA_y6C5KwX3OeeBFoo2Jl_jXSsFWcWERQe2U-yTjlDIpw#_3 http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement http://www.tkuhn.ch/bel2nanopub/RA_y6C5KwX3OeeBFoo2Jl_jXSsFWcWERQe2U-yTjlDIpw#assertion http://www.w3.org/2000/01/rdf-schema#label p(MGI:Csf1r) -> p(MGI:Il1a) http://www.tkuhn.ch/bel2nanopub/RA_y6C5KwX3OeeBFoo2Jl_jXSsFWcWERQe2U-yTjlDIpw#provenance http://resource.belframework.org/belframework/1.0/knowledge/large_corpus.bel http://purl.org/dc/elements/1.1/description Approximately 61,000 statements. http://resource.belframework.org/belframework/1.0/knowledge/large_corpus.bel http://purl.org/dc/elements/1.1/rights Copyright (c) 2011-2012, Selventa. All rights reserved. http://resource.belframework.org/belframework/1.0/knowledge/large_corpus.bel http://purl.org/dc/elements/1.1/title BEL Framework Large Corpus Document http://resource.belframework.org/belframework/1.0/knowledge/large_corpus.bel http://purl.org/pav/authoredBy http://www.tkuhn.ch/bel2nanopub/RA_y6C5KwX3OeeBFoo2Jl_jXSsFWcWERQe2U-yTjlDIpw#_5 http://resource.belframework.org/belframework/1.0/knowledge/large_corpus.bel http://purl.org/pav/version 1.4 http://www.tkuhn.ch/bel2nanopub/RA_y6C5KwX3OeeBFoo2Jl_jXSsFWcWERQe2U-yTjlDIpw#_4 http://www.w3.org/ns/prov#value Treatment of the cells with M-CSF (25 or 50 ng/ml) and 11 microM amyloid beta-peptide 1-40 resulted in 70 times increase in IL-1alpha production than control or when treated alone. And treatment with c-fms, an antibody against M- CSF receptor resulted in 50% reduction in M-CSF augmentation of Amyloid beta peptide plus M-CSF with or without control or blocking antibodies. http://www.tkuhn.ch/bel2nanopub/RA_y6C5KwX3OeeBFoo2Jl_jXSsFWcWERQe2U-yTjlDIpw#_4 http://www.w3.org/ns/prov#wasQuotedFrom http://www.ncbi.nlm.nih.gov/pubmed/9694846 http://www.tkuhn.ch/bel2nanopub/RA_y6C5KwX3OeeBFoo2Jl_jXSsFWcWERQe2U-yTjlDIpw#_5 http://www.w3.org/2000/01/rdf-schema#label Selventa http://www.tkuhn.ch/bel2nanopub/RA_y6C5KwX3OeeBFoo2Jl_jXSsFWcWERQe2U-yTjlDIpw#assertion http://www.w3.org/ns/prov#hadPrimarySource http://www.ncbi.nlm.nih.gov/pubmed/9694846 http://www.tkuhn.ch/bel2nanopub/RA_y6C5KwX3OeeBFoo2Jl_jXSsFWcWERQe2U-yTjlDIpw#assertion http://www.w3.org/ns/prov#wasDerivedFrom http://resource.belframework.org/belframework/1.0/knowledge/large_corpus.bel http://www.tkuhn.ch/bel2nanopub/RA_y6C5KwX3OeeBFoo2Jl_jXSsFWcWERQe2U-yTjlDIpw#assertion http://www.w3.org/ns/prov#wasDerivedFrom http://www.tkuhn.ch/bel2nanopub/RA_y6C5KwX3OeeBFoo2Jl_jXSsFWcWERQe2U-yTjlDIpw#_4 http://www.tkuhn.ch/bel2nanopub/RA_y6C5KwX3OeeBFoo2Jl_jXSsFWcWERQe2U-yTjlDIpw#pubinfo http://www.tkuhn.ch/bel2nanopub/RA_y6C5KwX3OeeBFoo2Jl_jXSsFWcWERQe2U-yTjlDIpw http://purl.org/dc/terms/created 2014-07-03T14:31:00.234+02:00 http://www.tkuhn.ch/bel2nanopub/RA_y6C5KwX3OeeBFoo2Jl_jXSsFWcWERQe2U-yTjlDIpw http://purl.org/pav/createdBy http://orcid.org/0000-0001-6818-334X http://www.tkuhn.ch/bel2nanopub/RA_y6C5KwX3OeeBFoo2Jl_jXSsFWcWERQe2U-yTjlDIpw http://purl.org/pav/createdBy http://orcid.org/0000-0002-1267-0234